Accès gratuit
Numéro
Réanimation
Volume 24, Janvier 2015
Page(s) S291 - S296
Section Session Thématique
DOI https://doi.org/10.1007/s13546-014-0939-4
Publié en ligne 12 février 2016
  • Friesema EC, Ganguly S, Abdalla A, et al (2003) Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278:40128–40135 [CrossRef] [PubMed] [Google Scholar]
  • Friesema EC, Jansen J, Jachtenberg JW, et al (2008) Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol 22:1357–1369 [CrossRef] [PubMed] [Google Scholar]
  • Peeters RP, Kester MH, Wouters PJ, et al (2005) Increased thyroxine sulfate levels in critically ill patients as a result of a decreased hepatic type I deiodinase activity. J Clin Endocrinol Metab 90:6460–6465 [CrossRef] [PubMed] [Google Scholar]
  • Cheng SY, Leonard JL, Davis PJ (2010) Molecular aspects of thyroid hormone actions. Endocr Rev 31:139–170 [CrossRef] [PubMed] [Google Scholar]
  • Farwell AP (2013) Nonthyroidal illness syndrome. Curr Opin Endocrinol Diabetes Obes 20:478–484 [CrossRef] [PubMed] [Google Scholar]
  • De Groot LJ (1999) Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 84:151–164 [CrossRef] [PubMed] [Google Scholar]
  • Mebis L, van den Berghe G (2009) The hypothalamuspituitary-thyroid axis in critical illness. Neth J Med 67:332–340 [PubMed] [Google Scholar]
  • Van den Berghe G (2014) Non-Thyroidal Illness in the ICU: a Syndrome with Different Faces. Thyroid [PubMed] [Google Scholar]
  • Chopra IJ (1997) Clinical review 86: Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab 82:329–334 [CrossRef] [PubMed] [Google Scholar]
  • Arem R, Wiener GJ, Kaplan SG, et al (1993) Reduced tissue thyroid hormone levels in fatal illness. Metabolism 42:1102–1108 [CrossRef] [PubMed] [Google Scholar]
  • Peeters RP, Wouters PJ, Kaptein E, et al (2003) Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 88:3202–3211 [CrossRef] [PubMed] [Google Scholar]
  • Debaveye Y, Ellger B, Mebis L, et al (2005) Tissue deiodinase activity during prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2. Endocrinology 146:5604–5611 [CrossRef] [PubMed] [Google Scholar]
  • Berger MM, Lemarchand-Beraud T, Cavadini C, Chiolero R (1996) Relations between the selenium status and the low T3 syndrome after major trauma. Intensive Care Med 22:575–581 [CrossRef] [PubMed] [Google Scholar]
  • Afandi B, Schussler GC, Arafeh AH, et al (2000) Selective consumption of thyroxine-binding globulin during cardiac bypass surgery. Metabolism 49:270–274 [CrossRef] [PubMed] [Google Scholar]
  • Afandi B, Vera R, Schussler GC, Yap MG (2000) Concordant decreases of thyroxine and thyroxine binding protein concentrations during sepsis. Metabolism 49:753–754 [CrossRef] [PubMed] [Google Scholar]
  • den Brinker M, Joosten KF, Visser TJ, et al (2005) Euthyroid sick syndrome in meningococcal sepsis: the impact of peripheral thyroid hormone metabolism and binding proteins. J Clin Endocrinol Metab 90:5613–5620 [CrossRef] [PubMed] [Google Scholar]
  • Chopra IJ, Huang TS, Beredo A, et al (1985) Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3, 5, 3’- triiodothyronine in sera of patients with nonthyroidal illnesses. J Clin Endocrinol Metab 60:666–672 [CrossRef] [PubMed] [Google Scholar]
  • Stockigt JR, Lim CF (2009) Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. Best Pract Res Clin Endocrinol Metab 23:753–767 [CrossRef] [PubMed] [Google Scholar]
  • Lim CF, Docter R, Visser TJ, et al (1993) Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids. J Clin Endocrinol Metab 76:1165–1172 [PubMed] [Google Scholar]
  • Mebis L, Paletta D, Debaveye Y, et al (2009) Expression of thyroid hormone transporters during critical illness. Eur J Endocrinol 161:243–250 [CrossRef] [PubMed] [Google Scholar]
  • Thijssen-Timmer DC, Peeters RP, Wouters P, et al (2007) Thyroid hormone receptor isoform expression in livers of critically ill patients. Thyroid 17:105–112 [CrossRef] [PubMed] [Google Scholar]
  • Romijn JA, Wiersinga WM (1990) Decreased nocturnal surge of thyrotropin in nonthyroidal illness. J Clin Endocrinol Metab 70:35–42 [CrossRef] [PubMed] [Google Scholar]
  • Hamblin PS, Dyer SA, Mohr VS, et al (1986) Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab 62:717–722 [CrossRef] [PubMed] [Google Scholar]
  • Fliers E, Noppen NW, Wiersinga WM, et al (1994) Distribution of thyrotropin-releasing hormone (TRH)-containing cells and fibers in the human hypothalamus. J Comp Neurol 350:311–323 [CrossRef] [PubMed] [Google Scholar]
  • Fliers E, Guldenaar SE, Wiersinga WM, Swaab DF (1997) Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab 82:4032–4036 [PubMed] [Google Scholar]
  • Bianco AC, Nunes MT, Hell NS, Maciel RM (1987) The role of glucocorticoids in the stress-induced reduction of extrathyroidal 3, 5, 3’-triiodothyronine generation in rats. Endocrinology 120:1033–1038 [CrossRef] [PubMed] [Google Scholar]
  • Nicoloff JT, Fisher DA, Appleman MD, Jr. (1970) The role of glucocorticoids in the regulation of thyroid function in man. J Clin Invest 49:1922–1929 [CrossRef] [PubMed] [Google Scholar]
  • Van den Berghe G, de Zegher F, Baxter RC, et al (1998) Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab 83:309–319 [PubMed] [Google Scholar]
  • Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM (1993) Association between serum interleukin-6 and serum 3, 5, 3’-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab 77:1695–1699 [PubMed] [Google Scholar]
  • Boelen A, Schiphorst MC, Wiersinga WM (1996) Relationship between serum 3, 5, 3’-triiodothyronine and serum interleukin-8, interleukin-10 or interferon gamma in patients with nonthyroidal illness. J Endocrinol Invest 19:480–483 [CrossRef] [PubMed] [Google Scholar]
  • van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP (1990) Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 71:1567–1572 [CrossRef] [PubMed] [Google Scholar]
  • Hermus RM, Sweep CG, van der Meer MJ, et al (1992) Continuous infusion of interleukin-1 beta induces a nonthyroidal illness syndrome in the rat. Endocrinology 131:2139–2146 [PubMed] [Google Scholar]
  • Boelen A, Platvoet-ter Schiphorst MC, Bakker O, Wiersinga WM (1995) The role of cytokines in the lipopolysaccharide-induced sick euthyroid syndrome in mice. J Endocrinol 146:475–483 [CrossRef] [PubMed] [Google Scholar]
  • van der Poll T, Van Zee KJ, Endert E, et al (1995) Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man. J Clin Endocrinol Metab 80:1341–1346 [PubMed] [Google Scholar]
  • Boelen A, Platvoet-ter Schiphorst MC, Wiersinga WM (1997) Immunoneutralization of interleukin-1, tumor necrosis factor, interleukin-6 or interferon does not prevent the LPS-induced sick euthyroid syndrome in mice. J Endocrinol 153:115–122 [CrossRef] [PubMed] [Google Scholar]
  • Acker CG, Singh AR, Flick RP, et al (2000) A trial of thyroxine in acute renal failure. Kidney Int 57:293–298 [CrossRef] [PubMed] [Google Scholar]
  • Klemperer JD, Klein I, Gomez M, et al (1995) Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333:1522–1527 [CrossRef] [PubMed] [Google Scholar]
  • Ross OC, Petros A (2001) The sick euthyroid syndrome in paediatric cardiac surgery patients. Intensive Care Med 27:1124–1132 [CrossRef] [PubMed] [Google Scholar]
  • Bettendorf M, Schmidt KG, Grulich-Henn J, et al (2000) Triiodothyronine treatment in children after cardiac surgery: a doubleblind, randomised, placebo-controlled study. Lancet 356:529–534 [CrossRef] [PubMed] [Google Scholar]
  • Imberti R, Ferrari M, Albertini R, et al (2010) Increased levothyroxine requirements in critically ill patients with hypothyroidism. Minerva Anestesiol 76:500–503 [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.